M6620 Plus Standard Treatment in Oesophageal and Other Cancer

Conditions:   Oesophageal Adenocarcinoma;   Squamous Cell Carcinoma;   Solid Tumor
Interventions:   Drug: M6620;   Drug: Cisplatin;   Drug: Capecitabine;   Radiation: Radiotherapy
Sponsors:   University of Oxford;   Merck KGaA
Not yet recruiting

https://ift.tt/2Lkq8RT